Plus, health insurance startup Oscar to build concierge clinic in Arizona, AIDS Healthcare Foundation wants the FDA and Congress to investigate Gilead and eHealth hires its new CEO from Playboy.
Plus, UCSF receives $185 million gift for neurosciences institute and New York doc charged with writing 300,000 illegal painkiller prescriptions.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Valeant Pharmaceuticals just poached Perrigo CEO Joseph Papa to be its new chief executive. He'll replace the somewhat reviled current CEO, Michael Pearson, in early May.
Also, CEO succession plans at GSK, Sanofi's plans to buy orphan drug companies, doctors healthcare social media habits and long looks at Bernie Sanders and Donald Trump's health plans.
Also, new details about consumer attitudes toward healthcare and a Japanese ad agency invests in health trackers.
A lengthy takeout in the Wall Street Journal with a passive-aggressive headline is never a good sign.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Maybe Martin Shkreli will have a bit of a breather now that Valeant's Michael Pearson is keeping the hot seat warm.